Zepp Health Corporation reported unaudited financial results for the third quarter of 2025, with revenue reaching $75.8 million, a 78.5% year-over-year increase. The company recorded a GAAP operating loss of $0.9 million and adjusted operating income of $0.4 million, compared to losses of $12.5 million and $11.3 million, respectively, in the same period of 2024. Net loss attributable to Zepp Health was $1.6 million, down from $13.3 million last year, while adjusted net loss was $0.7 million, compared to $11.8 million in the third quarter of 2024. Adjusted expenses as a percentage of sales improved to 37.7% from 67.3% in the prior year. Zepp Health reduced its total loan balance by $64.5 million since early 2023 and plans to continue its share repurchase program in 2026. For the fourth quarter of 2025, the company expects revenue between $82.0 million and $86.0 million, representing a projected year-over-year increase of 38% to 45%.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zepp Health Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CN15063) on November 05, 2025, and is solely responsible for the information contained therein.
Comments